HPV vaccine coverage among men who have sex with men - National HIV Behavioral Surveillance System, United States, 2011

for the NHBS study group

Research output: Contribution to journalArticle

25 Scopus citations

Abstract

Men who have sex with men (MSM) are at high risk for disease associated with human papillomavirus (HPV). In late 2011, HPV vaccine was recommended for males through age 21 and MSM through age 26. Using data from the 2011 National HIV Behavioral Surveillance System, we assessed self-reported HPV vaccine uptake among MSM, using multivariate analysis to calculate adjusted prevalence ratios (aPRs) and 95% confidence intervals (CIs). Among 3221 MSM aged 18-26, 157 (4.9%) reported ≥1 vaccine dose. Uptake was higher among men who visited a healthcare provider (aPR 2.3, CI: 1.2-4.2), disclosed same-sex sexual attraction/behavior to a provider (aPR 2.1, CI: 1.3-3.3), reported a positive HIV test (aPR 2.2, CI: 1.5-3.2), or received hepatitis vaccine (aPR 3.9, CI: 2.4-6.4). Of 3064 unvaccinated MSM, 2326 (75.9%) had visited a healthcare provider within 1 year. These national data on HPV vaccine uptake among MSM provide a baseline as vaccination recommendations are implemented.

Original languageEnglish (US)
Pages (from-to)6356-6359
Number of pages4
JournalVaccine
Volume32
Issue number48
DOIs
StatePublished - Nov 12 2014

Keywords

  • Human papillomavirus (HPV)
  • Men who have sex with men (MSM)
  • Vaccine uptake

ASJC Scopus subject areas

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Fingerprint Dive into the research topics of 'HPV vaccine coverage among men who have sex with men - National HIV Behavioral Surveillance System, United States, 2011'. Together they form a unique fingerprint.

  • Cite this